Rhythm Pharmaceuticals gains on report of additional bidder

Rhythm Pharmaceuticals jumps on a reported second bidder after AstraZeneca’s near-$10B offer.

1 sources · 1 articles · updated 2026-11-06 16:06 UTC · business

Coverage